Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. ESMO
  2. Meeting Calendar
  3. Past Meetings
  4. ESMO Congress 2024
  5. Satellite Symposia Webcasts

F. Hoffmann - La Roche Ltd - How can we PI3K the right treatment for every patient with HR+ breast cancer?

PI3Ki: An evolving drug class with an exciting future

Date

16 Sep 2024

Session

F. Hoffmann - La Roche Ltd - How can we PI3K the right treatment for every patient with HR+ breast cancer?

Topics

Tumour Site

Breast Cancer

Presenters

Carlos Barrios

Authors

C.H.E. Barrios

Author affiliations

  • Oncology Research Center, Latin American Cooperative Oncology Group, 90619-900 - Porto Alegre/BR

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Welcome

Presenter: Carlos Barrios

Session: F. Hoffmann - La Roche Ltd - How can we PI3K the right treatment for every patient with HR+ breast cancer?

Resources:

Webcast

Q&A

Presenter: Carlos Barrios, Komal Jhaveri, Kevin Kalinsky

Session: F. Hoffmann - La Roche Ltd - How can we PI3K the right treatment for every patient with HR+ breast cancer?

Resources:

Webcast

Close

Presenter: Kevin Kalinsky

Session: F. Hoffmann - La Roche Ltd - How can we PI3K the right treatment for every patient with HR+ breast cancer?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.